Liên Minh Châu Âu - Tiếng Romania - EMA (European Medicines Agency)

novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - imunosupresoare - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriazică arthritiscosentyx, singur sau în asociere cu metotrexat (mtx), este indicat pentru tratamentul artritei psoriazice active la pacienții adulți, atunci când răspunsul la precedenta modificare a bolii anti-reumatice droguri (marmb) a fost terapia inadecvată. spondilartrită axială (axspa)spondilita anchilozantă (ca, radiografic spondilartrită axială)cosentyx este indicat pentru tratamentul de spondilită anchilozantă activă la adulți care au răspuns inadecvat la terapia convențională. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.

Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glaxo smithkline biologicals s.a. - belgia - vaccin rujeolic,rubeolic,urlian,varicelic,viu. - pulb+solv.pt.sol.inj. in seringa preumpluta - vaccinuri virale vaccinuri rujeolice

Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glaxosmithkline biologicals s.a. - belgia - vaccin varicelic viu atenuat - pulb.+solv. pt. sol. inj. - 10³,³ pfu /0,5 ml - vaccinuri virale vaccinuri varicelo-zoosteriene

Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

panpharma - franta - kanamycinum - pulb. pt. sol. inj./perf. - 1g - antibiotice aminoglicozidice alte aminoglicozide

Liên Minh Châu Âu - Tiếng Romania - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenți pentru dermatită, cu excepția corticosteroizilor - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glaxosmithkline biologicals sa - belgia - vaccin rujeolic,rubeolic,urlian,varicelic,viu. - pulb. si solv. pt. sol. inj. in seringa preumpluta - vaccinuri virale vaccinuri rujeolice

Moldova - Tiếng Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

glaxosmithkline biologicals s.a. - vaccin difteric, tetanic, pertussis, hepatitic b, poliomielitic și haemophilus influenzae tip b - ... - pulbere şi suspensie pentru suspensie injectabilă - 1 doză

Liên Minh Châu Âu - Tiếng Romania - EMA (European Medicines Agency)

leo pharma a/s - tralokinumab - dermatita, atopică - alte preparate dermatologice - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.

Moldova - Tiếng Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dhg pharmaceutical jsc - spiramycinum - comprimate filmate - 3 mil. ui

Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sanofi pasteur - franta - vaccin gripal inactivat - susp. inj. in seringa preumpluta - vaccinuri virale vaccinuri gripale